Notably, heterozygous germ‐line pathological variants (PVs) in tumour suppressor genes such as BRCA2 significantly elevate PCa risk, particularly in men under 65 years old, and serve as an independent prognostic factor for poorer outcomes.4, 5. Here, BRCA2 is linked to posterior cortical atrophy.